-
Mashup Score: 1Bryan Johnson discontinues longevity drug, after concerns it may have accelerated aging | - Times of India - 16 day(s) ago
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged hi
Source: timesofindia.indiatimes.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Why Are Recurring Dreams Usually Nightmares? - 16 day(s) ago
Recurring dreams may feature taking a test the dreamer didn’t study for, having to make a speech or being attacked. Here’s why our sleeping brain comes back to these unpleasant dreams again and again
Source: www.scientificamerican.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1JPM25: Vertex CEO says pain is its next multi-billion franchise - 16 day(s) ago
Vertex’s leaders projected confidence in the firm’s non-opioid pain franchise at the JP Morgan Healthcare Conference on Monday, although the first cut of data for lead candidate suzetrigine in peri…
Source: ml.firstwordpharma.comCategories: General Medicine News, General HCPsTweet-
JPM25: Vertex CEO says pain is its next multi-billion franchise https://t.co/qN5lYewGxZ ""The efficacy was as expected, the safety was as expected, but the #placebo was larger than expected," [David] Altshuler said of the results" Dang placebos! Opioids are very inexpensive.… https://t.co/nhY8obq4ZW
-
-
Mashup Score: 0
The framework explores ways to spur innovation and adoption, enable more trustworthy model development, promote access and foster AI-empowered healthcare workforces.
Source: www.healthcareitnews.comCategories: General Medicine News, General HCPsTweet-
#HHS Artificial Intelligence Strategic Plan: https://t.co/O5d2q697ws Benefits: 1. Catalyzing health AI innovation and adoption to unlock new ways to improve people’s lives. 2. Promoting trustworthy AI development and ethical and responsible use to avoid potential harm. 3.… https://t.co/hbZOTonulK https://t.co/ns8p1u0xVD
-
-
Mashup Score: 0Public Sharing of Adverse Events of Gene Therapy Trials - 16 day(s) ago
This Viewpoint describes the need for public sharing of adverse events associated with genetic therapies to improve patient safety.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Geographical Disparities in Research Misconduct: Analyzing Retraction Patterns by Country - 16 day(s) ago
This study examines disparities in research retractions due to misconduct, identifying countries with the highest retraction counts and those disproportionately represented relative to population and publication output. The findings emphasize the need for improved research integrity measures.
Source: www.jmir.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The Truveta collaboration will extend Regeneron Genetics Center’s ® (RGC TM ) world-leading DNA sequence-linked healthcare database (now including almost three million de-identified patient volunteers) through genetic sequencing of up to ten million additional patient volunteers, all with linked
Source: investor.regeneron.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
/PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Neuron type-specific mRNA translation programs provide a gateway for memory consolidation. - 17 day(s) ago
Long-term memory consolidation is a dynamic process that requires a heterogeneous ensemble of neurons, each with a highly specialized molecular environment. Considerable effort has been placed into understanding how the molecular mechanisms in specific neuron types are modified in memory, but these studies are often undertaken hours or days after training, when memory is already consolidated. Studies have shown that protein synthesis is elevated during the early stages of consolidation, but there is limited information as to how it impacts neuronal function. We hypothesize that mRNAs being translated during the early stages of consolidation could provide clues as to how diverse neurons involved in memory formation restructure their molecular architecture to support memory formation. Here, we generate a landscape of the translatome of three neuron types in the dorsal hippocampus during the first hour of contextual memory consolidation. Our results show that these neurons share a common
Source: www.biorxiv.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Vertex on the Verge of Breakthrough for Nonopioid Pain Management as NOPAIN Act Takes Effect - 17 day(s) ago
Suzetrigine, the investigational selective NaV1.8 pain signal inhibitor, with a PDUFA date of Jan 30, could become a first-in-class nonopioid analgesic.
Source: www.patientcareonline.comCategories: General Medicine News, General HCPsTweet-
Vertex on the Verge of Breakthrough for Nonopioid Pain Management as NOPAIN Act Takes Effect https://t.co/HddzBDZW4X via @PatCareOnline #VX_548 "#Suzetrigine, the investigational oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute… https://t.co/nTqtJqswg3
-
Bryan Johnson, a tech entrepreneur, has stopped using #rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged hi Source: The Times of India https://t.co/YvrUnpP3yn